Fierce Pharma
SEPTEMBER 30, 2024
After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound in 2025. | Ahead of the CPHI conference in Milan, the events group has teased new research signaling an expected rebound for the CDMO industry—and a rejection of the BIOSECURE Act.
MedCity News
SEPTEMBER 30, 2024
In this month’s episode, Senior Reporter Katie Adams explored some of the executive moves, exits and layoffs that recently occurred in the healthcare sector. She also interviewed Dr. Jayne Morgan, who recently became vice president of medical affairs at Hello Heart. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Dr. Jayne Morgan, VP of Medical Affairs at Hello Heart appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 30, 2024
After putting on a strong performance in preventing disease progression in the earlier treatment of multiple myeloma, Johnson & Johnson and Legend Biotech’ Carvykti has once again mounted a maj | After putting on a strong performance in preventing disease progression, Johnson & Johnson and Legend Biotech’s Carvykti has once again demonstrated a major benefit—this time in prolonging patients’ lives.
Pharmaceutical Technology
SEPTEMBER 30, 2024
The first needle-free epinephrine nasal spray, Neffy by ARS Pharmaceuticals, represents a significant breakthrough in emergency treatment for type I allergic reactions.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
SEPTEMBER 30, 2024
With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease. | With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease. Still, with months of prep work and outreach complete, the company is already proving it can hit the ground running.
MedCity News
SEPTEMBER 30, 2024
Memorial Hermann Health System and Moffitt Cancer Center have recently struck partnerships with Reimagine Care, a startup focused on providing support to cancer patients via an AI assistant and text messages with oncology experts. The post Health Systems Are Partnering with Reimagine Care to Improve Cancer Treatment appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
SEPTEMBER 30, 2024
The company’s allogeneic therapy was OK’d in the EU and could become the first of its kind approved by the FDA in January — while eyeing the next frontier.
MedCity News
SEPTEMBER 30, 2024
By embracing available data, cutting-edge technology, and an intelligent marketplace, payers can design solutions that optimize costs across the entire healthcare ecosystem. The post Payers Possess the Tools to Tackle Rising Healthcare Costs appeared first on MedCity News.
Pharmaceutical Commerce
SEPTEMBER 30, 2024
Why looming benefit changes—and the resulting unintended consequences—are a concern for patients.
MedCity News
SEPTEMBER 30, 2024
Healthy Young Minds is an online youth mental health startup. It was recently crowned winner of MedCity News’ INVEST Pitch Perfect contest focused on pediatric mental health. The post INVEST Pitch Perfect Spotlight: How One Startup Aims To Become the Leading Medicaid Mental Health Provider for Kids appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Commerce
SEPTEMBER 30, 2024
Why this trend is occurring and ways that drugmakers are pivoting in order to remedy the situation.
MedCity News
SEPTEMBER 30, 2024
Bristol Myers Squibb is turning to the prime-editing technology of Prime Medicines for the R&D of new cell therapies for cancer and immunology. The pharma giant is paying $110 million up front to begin the collaboration. The post Gene-Editing Biotech Prime Medicine Strikes Up Cell Therapy R&D Alliance With Bristol Myers Squibb appeared first on MedCity News.
pharmaphorum
SEPTEMBER 30, 2024
Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy Nicole.
European Pharmaceutical Review
SEPTEMBER 30, 2024
177 Lu-Dotatate has shown potential for extending progression-free survival for patients with the brain cancer meningioma, with results showing more favourable improvements compared to historical benchmarks. The Phase II clinical trial investigated whether refractory meningioma can be treated with theranostics. This treatment approach uses radiopharmaceuticals and provides patients with potentially a more effective treatment option, the researchers explained.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PM360
SEPTEMBER 30, 2024
Digital disruption in the pharma sector is being slowed down by budget constraints, and that does not seem like it’s going to change any time soon, according to new research from digital experience agency Graphite Digital. The Disconnected Pharma report reveals pharma companies are keen on strengthening their digital capabilities and offerings, setting a foundation for them to build upon as their customers’ needs change and new technologies emerge. 37 percent of pharma leaders want to ensure tha
Pharmaceutical Technology
SEPTEMBER 30, 2024
Medidata is a winner in the Innovation, and Product Launches categories in the 2024 Pharmaceutical Technology Excellence Awards.
PM360
SEPTEMBER 30, 2024
for Your Brand, Company, or the Industry as a Whole Building trust equity in the pharmaceutical industry hinges on a commitment to transparency, reliability, and ethical practices. Engaging with healthcare professionals and patients through educational initiatives and open dialogue helps to demystify complex information and foster a sense of reliability between the two.
Pharmaceutical Technology
SEPTEMBER 30, 2024
The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.
PM360
SEPTEMBER 30, 2024
PM360’s Focus On section examines a specific area of the life sciences industry. In this issue, we take a closer look at the patient experience and how it is constantly evolving in the pharma industry. From conducting an easier process of scheduling doctors appointments to how patient feedback plays an important role in enhancing the experience, here is what our specialists had to say.
pharmaphorum
SEPTEMBER 30, 2024
Genentech buys Regor's next-gen CDK inhibitors for $850M Jonah.
Pharmaceutical Commerce
SEPTEMBER 30, 2024
Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.
Rep-Lite
SEPTEMBER 30, 2024
Hiring the wrong candidate for a medical sales role can have significant repercussions for a company beyond what may appear on the surface. In an industry where knowledge, relationships, and compliance are critical, a bad hiring decision can lead to not only financial losses in both internal and external recruitment costs but also lasting damage to business operations and reputation.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTech
SEPTEMBER 30, 2024
In vitro transcription (IVT) is often used to make mRNA, and in co-transcriptional capping an analog cap can be used to cap the mRNA. This paper reviews the recent history of capping analogs in addition to a state-of-the-art approach to improve protein expression.
Healthcare Success
SEPTEMBER 30, 2024
Managing successful Google Ads campaigns is more than just winning clicks—it’s about converting those clicks into results (e.g., new patients or B2B inquiries). At Healthcare Success, we manage millions of dollars in Google Ads spend for our healthcare clients. We often see the following 13 mistakes tank conversion rates. But don’t worry—13 isn’t unlucky here.
PharmaTech
SEPTEMBER 30, 2024
This Behind the Headlines news roundup panel discussion discusses news items such as research results from the June Lab at the University of Pennsylvania presented at the Hanson Wade 9th CAR-TCR Summit; winter vaccine recommendations, particularly for respiratory syncytial virus (RSV) and Beyfortus access and deployment; upcoming early October Nobel prize announcement predictions; digital biology analytics, quantitation, alongside point of care (POC) and distributed manufacturing.
Pharmaceutical Commerce
SEPTEMBER 30, 2024
In the second part of his interview with Pharma Commerce Editor Nicholas Saraceno, Gautam Prem Jain, GoComet’s Co-founder and CEO, explains the sales and operations planning (SO&P) process that can help create logistical efficiencies.
PharmaTech
SEPTEMBER 30, 2024
The company is touting its HPC74 series, which it said features heat-seal coated construction and has the highest puncture and tear strength of all of its reinforced medical papers to date.
PharmExec
SEPTEMBER 30, 2024
In this part of his Pharmaceutical Executive video interview, Jonathan Scheinberg, of the Northeast Science and Technology Center, discusses what specific areas of research and development are likely to benefit the most from this influx of of venture capital and federal funding.
Pharmaceutical Technology
SEPTEMBER 30, 2024
Valerio Therapeutics, a developer of DNA Decoy therapeutics, has announced its acquisition of Emglev Therapeutics, a company specialising in single-domain antibody-based therapeutics.
PM360
SEPTEMBER 30, 2024
PM360 Q&A WITH FRANK BURREL CEO Deerfield Group Frank Burrell is CEO of Deerfield Group, bringing more than 20 years of agency and client experience to implement marketing strategies across multiple therapeutic categories for specialty and retail products. Frank works as a valued partner to provide comprehensive marketing solutions that not only drive revenue but can be easily integrated within a company’s infrastructure.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
277 
Let's personalize your content